BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11585118)

  • 1. Levels of tissue inhibitor of metalloproteinases-1 and matrix metalloproteinases-1 and -8 in gingival crevicular fluid following treatment with enamel matrix derivative (EMDOGAIN).
    Okuda K; Miyazaki A; Momose M; Murata M; Nomura T; Kubota T; Wolff LF; Yoshie H
    J Periodontal Res; 2001 Oct; 36(5):309-16. PubMed ID: 11585118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.
    Tüter G; Kurtiş B; Serdar M
    J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue inhibitor of metalloproteinases-1, matrix metalloproteinases-1 and -8, and collagenase activity levels in peri-implant crevicular fluid after implantation.
    Nomura T; Ishii A; Shimizu H; Taguchi N; Yoshie H; Kusakari H; Hara K
    Clin Oral Implants Res; 2000 Oct; 11(5):430-40. PubMed ID: 11168235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gingival crevicular fluid can degrade Emdogain and inhibit Emdogain-induced proliferation of periodontal ligament fibroblasts.
    Laaksonen M; Salo T; Vardar-Sengul S; Atilla G; Saygan BH; Simmer JP; Baylas H; Sorsa T
    J Periodontal Res; 2010 Jun; 45(3):353-60. PubMed ID: 19909398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enamel matrix derivative induces the expression of tissue inhibitor of matrix metalloproteinase-3 in human gingival fibroblasts via extracellular signal-regulated kinase.
    Zeldich E; Koren R; Dard M; Weinberg E; Weinreb M; Nemcovsky CE
    J Periodontal Res; 2010 Apr; 45(2):200-6. PubMed ID: 19909407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease.
    Emingil G; Tervahartiala T; Mãntylã P; Määttä M; Sorsa T; Atilla G
    J Periodontol; 2006 Dec; 77(12):2040-50. PubMed ID: 17209789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase (MMP)-8 and tissue inhibitor of MMP-1 (TIMP-1) gene polymorphisms in generalized aggressive periodontitis: gingival crevicular fluid MMP-8 and TIMP-1 levels and outcome of periodontal therapy.
    Emingil G; Han B; Gürkan A; Berdeli A; Tervahartiala T; Salo T; Pussinen PJ; Köse T; Atilla G; Sorsa T
    J Periodontol; 2014 Aug; 85(8):1070-80. PubMed ID: 24283658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis.
    Alpagot T; Bell C; Lundergan W; Chambers DW; Rudin R
    J Clin Periodontol; 2001 Apr; 28(4):353-9. PubMed ID: 11314892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: the relevance to periodontal diseases.
    Nomura T; Ishii A; Oishi Y; Kohma H; Hara K
    Oral Dis; 1998 Dec; 4(4):231-40. PubMed ID: 10200701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study.
    Wachtel H; Schenk G; Böhm S; Weng D; Zuhr O; Hürzeler MB
    J Clin Periodontol; 2003 Jun; 30(6):496-504. PubMed ID: 12795787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients.
    Ingman T; Tervahartiala T; Ding Y; Tschesche H; Haerian A; Kinane DF; Konttinen YT; Sorsa T
    J Clin Periodontol; 1996 Dec; 23(12):1127-32. PubMed ID: 8997658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study.
    Hernández M; Gamonal J; Tervahartiala T; Mäntylä P; Rivera O; Dezerega A; Dutzan N; Sorsa T
    J Periodontol; 2010 Nov; 81(11):1644-52. PubMed ID: 20653434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enamel matrix derivative in the treatment of human intrabony osseous defects.
    Okuda K; Momose M; Miyazaki A; Murata M; Yokoyama S; Yonezawa Y; Wolff LF; Yoshie H
    J Periodontol; 2000 Dec; 71(12):1821-8. PubMed ID: 11156038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy.
    Buduneli N; Vardar S; Atilla G; Sorsa T; Luoto H; Baylas H
    J Periodontol; 2002 Jan; 73(1):103-9. PubMed ID: 11846190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis.
    Choi DH; Moon IS; Choi BK; Paik JW; Kim YS; Choi SH; Kim CK
    J Periodontal Res; 2004 Feb; 39(1):20-6. PubMed ID: 14687223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics.
    Kardeşler L; Biyikoğlu B; Cetinkalp S; Pitkala M; Sorsa T; Buduneli N
    Oral Dis; 2010 Jul; 16(5):476-81. PubMed ID: 20233316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of gingival crevicular fluid transforming growth factor-β1 level after treatment of intrabony periodontal defects with enamel matrix derivatives and autogenous bone graft: A randomized controlled clinical trial.
    Agrali ÖB; Kuru BE; Yarat A; Kuru L
    Niger J Clin Pract; 2016; 19(4):535-43. PubMed ID: 27251974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered relationship between MMP-8 and TIMP-2 in gingival crevicular fluid in adolescents with Down's syndrome.
    Tsilingaridis G; Yucel-Lindberg T; Modéer T
    J Periodontal Res; 2013 Oct; 48(5):553-62. PubMed ID: 23298307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis.
    Emingil G; Atilla G; Sorsa T; Luoto H; Kirilmaz L; Baylas H
    J Periodontol; 2004 Jan; 75(1):106-15. PubMed ID: 15025222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in gingival crevicular fluid during orthodontic tooth movement.
    Bildt MM; Bloemen M; Kuijpers-Jagtman AM; Von den Hoff JW
    Eur J Orthod; 2009 Oct; 31(5):529-35. PubMed ID: 19299245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.